Idarucizumab - Open Access .click

Results 31 to 40 of about 4,961 (248)

Ischemic stroke following reversal of dabigatran with idarucizumab in spontaneous subdural hematoma in cerebral venous thrombosis [PDF]

International Journal of Research in Medical Sciences
Spontaneous subdural hematomas (SDH) are an unusual but potentially devastating complication of oral anticoagulation. Emergency management of subdural hematomas following oral anticoagulant therapy consists of reversal of anticoagulation coupled with ...
Thanisha Santhosh +4 more
semanticscholar +3 more sources

Idarucizumab: A novel antidote for reversal of dabigatran [PDF]

Asian Journal of Neurosurgery, 2015
Abdul Rehman, Muhammad Awais, Noor Ul-Ain Baloch +2 more
openalex +5 more sources

Successful use of idarucizumab for the management of intracranial hemorrhage in an elderly woman receiving dabigatran for stroke prevention in atrial fibrillation: A case report

IHJ Cardiovascular Case Reports, 2018
Non-vitamin K antagonist oral anticoagulants are effective for prevention of stroke in atrial fibrillation (AF) but management of emergency situations in some patients receiving these drugs can be challenging.
Manoj Mashru +4 more
doaj +2 more sources

[Budget impact analysis of idarucizumab for the management of patients treated with dabigatran in emergency / urgent situations in Italy] [PDF]

Farmeconomia: Health Economics and Therapeutic Pathways, 2016
BACKGROUND: Each drug therapy with an anticoagulant effect may require, in emergency conditions, a rapid and specific strategy for a prompt restoration of coagulation.
Andrea Belisari +7 more
doaj +5 more sources

Dabigatran-reversal failure using standard dose of idarucizumab: a systematic review and meta-analysis of cases. [PDF]

Res Pract Thromb Haemost, 2023
Melicine S +7 more
europepmc +2 more sources

2025 Guidelines for direct oral anticoagulants: a practical guidance on the prescription, laboratory testing, peri-operative and bleeding management. [PDF]

Intern Med J
Abstract Direct oral anticoagulants (DOACs) are widely prescribed to prevent and treat venous and arterial thromboembolism, supported by published evidence, and are preferred over warfarin in many guidelines. Although the risk of major bleeding, in particular intracranial haemorrhage (ICH), is decreased with DOACs, gastrointestinal bleeding is ...
Tran HA +7 more
europepmc +2 more sources

Idarucizumab for dabigatran overdose in a child [PDF]